Is bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?

Journal of Neurochemistry

Volumn 76, Issue 6, 2001, Pages 1785-1793

  Hartmann, Andreas ^a   Michel, Patrick P ^a   Troadec, Jean Denis ^a   Mouatt Prigent, Annick ^a   Faucheux, Baptiste A ^a   Ruberg, Merle ^a   Agid, Yves ^a   Hirsch, Etienne C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Apoptosis; Bax; Cytochrome c; Mitochondria; MPP+; Parkinson's disease

Indexed keywords

CYTOCHROME C; NEUROTOXIN; PROTEIN BAX; TYROSINE 3 MONOOXYGENASE;

AGED; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN MITOCHONDRION; CHROMATIN CONDENSATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; ENZYME ACTIVATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEWY BODY; MESENCEPHALON; MITOCHONDRIAL MEMBRANE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT;

1-METHYL-4-PHENYLPYRIDINIUM; ADULT; AGED; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BRAIN; CELLS, CULTURED; DOPAMINE; EMBRYO; HUMANS; INTRACELLULAR MEMBRANES; LEWY BODIES; MESENCEPHALON; MITOCHONDRIA; NEURONS; PARKINSON DISEASE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR; REFERENCE VALUES; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

ANIMALIA;

EID: 0035103294     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00160.x     Document Type: Article

References (43)

1. Influence of age on hypoxia/reoxygenation-induced DNA fragmentation and bcl-2, bcl-x1, bax and fas in the rat heart and brain
2. Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons
3. + opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism
4. BAX is required for neuronal death after trophic factor deprivation and during development
5. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis
6. Peptide inhibitors of caspase-3-like proteases attenuate 1-methyl-4-phenylpyridium-induced toxicity of cultured fetal rat mesencephalic dopamine neurons
7. Caspase-3-like proteases and 6-hydroxydopamine induced cell death
8. Ageing and Parkinson's disease: Substantia nigra regional selectivity
9. Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: Relevance to Parkinson's disease
10. Caspase-3: A vulnerability factor and a final effector in the apoptotic death of dopaminergic neurons in Parkinson's disease
11. Increase in Bax expression in substantia nigra following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment of mice
12. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
13. Dopaminergic neurons degenerate by apoptosis in Parkinson's disease
14. Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis
15. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson disease
16. Understanding cell death in Parkinson's disease
17. Bax-deficient mice with lymphoid hyperplasia and male germ cell death
18. Upregulation of bax protein levels in neurons following cerebral ischemia
19. Mitochondrial control of cell death
20. Parkinson's disease. Second of two parts
21. Mitochondrial respiratory chain disorders II: Neurodegenerative disorders and nuclear gene defects
22. Inhibition of virus-induced neuronal apoptosis by Bax
23. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
24. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons
25. The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+)
26. Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neurons
27. Ventral mesencephalic (dopaminergic) and septal cholinergic neurons
28. Adenosine prevents the death of mesencephalic dopaminergic neurons by a mechanism that involves astrocytes
29. Differences in bcl-2- and bax-independent function in regulating apoptosis in sensory neuron populations
30. Apoptosis induced by 1-methyl-4-phenylpyridinium ion (MPP+) in ventral mesencephalic striatal co-culture in rat
31. Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: A role in nerve cell death?
32. Caspases mediate 6-hydoxydopamine-induced apoptosis but not necrosis in PC12 ceils
33. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death
34. BAX translocation is a critical event in neuronal apoptosis: Regulation by neuroprotectants, BCL-2, and caspases
35. Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injury
36. TUNEL-positive cells in the substantia nigra of C57BL/6 mice after a single bolus of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
37. In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system
38. Molecular characterization of mitochondriai apoptosis-inducing factor
39. Involvement of caspase-like proteinases in apoptosis of neuronal PC12 cells and primary cultured microglia induced by 6-hydroxydopamine
40. In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining
41. Bcl-2 and Bax proteins in Lewy bodies from patients with Parkinson's disease and diffuse Lewy body disease
42. Bcl-2 proteins: Regulators of apoptosis or of mitochondrial homeostasis?
43. Movement of Bax from the cytosol to mitochondria during apoptosis